Literature DB >> 19212389

Virology: Final entry key for hepatitis C.

Thomas Pietschmann.   

Abstract

Mesh：

Year:  2009        PMID： 19212389     DOI： 10.1038/457797a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.

Authors:  Carolyn B Coyne; Jeffrey M Bergelson
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

2.  Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.

Authors:  Olivier Silvie; Eric Rubinstein; Jean-François Franetich; Michel Prenant; Elodie Belnoue; Laurent Rénia; Laurent Hannoun; Wijnand Eling; Shoshana Levy; Claude Boucheix; Dominique Mazier
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

3.  Binding of hepatitis C virus to CD81.

Authors:  P Pileri; Y Uematsu; S Campagnoli; G Galli; F Falugi; R Petracca; A J Weiner; M Houghton; D Rosa; G Grandi; S Abrignani
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

4.  Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells.

Authors:  Qing Zhu; Ju-Tao Guo; Christoph Seeger
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

6.  Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection.

Authors:  Cristina D Rodrigues; Michael Hannus; Miguel Prudêncio; Cécilie Martin; Lígia A Gonçalves; Sílvia Portugal; Sabrina Epiphanio; Akin Akinc; Philipp Hadwiger; Kerstin Jahn-Hofmann; Ingo Röhl; Geert-Jan van Gemert; Jean-François Franetich; Adrian J F Luty; Robert Sauerwein; Dominique Mazier; Victor Koteliansky; Hans-Peter Vornlocher; Christophe J Echeverri; Maria M Mota
Journal:  Cell Host Microbe       Date:  2008-09-11       Impact factor: 21.023

Review 7.  Early steps of the hepatitis C virus life cycle.

Authors:  Jean Dubuisson; François Helle; Laurence Cocquerel
Journal:  Cell Microbiol       Date:  2007-12-13       Impact factor: 3.715

8.  Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

Authors:  Matthew J Evans; Thomas von Hahn; Donna M Tscherne; Andrew J Syder; Maryline Panis; Benno Wölk; Theodora Hatziioannou; Jane A McKeating; Paul D Bieniasz; Charles M Rice
Journal:  Nature       Date:  2007-02-25       Impact factor: 49.962

9.  Diverse CD81 proteins support hepatitis C virus infection.

Authors:  Mike Flint; Thomas von Hahn; Jie Zhang; Michelle Farquhar; Christopher T Jones; Peter Balfe; Charles M Rice; Jane A McKeating
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

10.  Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Authors:  Alexander Ploss; Matthew J Evans; Valeriya A Gaysinskaya; Maryline Panis; Hana You; Ype P de Jong; Charles M Rice
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962
View more
  8 in total

1.  Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate.

Authors:  Jieyun Jiang; Wei Cun; Xianfang Wu; Qing Shi; Hengli Tang; Guangxiang Luo
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Functional selection of hepatitis C virus envelope E2-binding Peptide ligands by using ribosome display.

Authors:  Fang Chen; Yinglan Zhao; Min Liu; Dongqing Li; Hongyan Wu; Haidan Chen; Yongzhe Zhu; Fengling Luo; Jin Zhong; Yidan Zhou; Zhongtian Qi; Xiao-Lian Zhang
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

3.  G protein-coupled receptors function as logic gates for nanoparticle binding and cell uptake.

Authors:  Wolfgang Hild; Klaus Pollinger; Andrea Caporale; Chiara Cabrele; Max Keller; Nicola Pluym; Armin Buschauer; Reinhard Rachel; Joerg Tessmar; Miriam Breunig; Achim Goepferich
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

4.  Griffithsin has antiviral activity against hepatitis C virus.

Authors:  Philip Meuleman; Anna Albecka; Sandrine Belouzard; Koen Vercauteren; Lieven Verhoye; Czeslaw Wychowski; Geert Leroux-Roels; Kenneth E Palmer; Jean Dubuisson
Journal:  Antimicrob Agents Chemother       Date:  2011-09-06       Impact factor: 5.191

5.  Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol.

Authors:  Elodie Teissier; Giorgia Zandomeneghi; Antoine Loquet; Dimitri Lavillette; Jean-Pierre Lavergne; Roland Montserret; François-Loïc Cosset; Anja Böckmann; Beat H Meier; François Penin; Eve-Isabelle Pécheur
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

6.  Liver stiffness using transient elastography is applicable to canines for hepatic disease models.

Authors:  Antonio Rivero-Juárez; Juan Morgaz; Angela Camacho; Pilar Muñoz-Rascón; Juan Manuel Dominguez; Raquel Sánchez-Céspedes; Julián Torre-Cisneros; Antonio Rivero
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

Review 7.  Lipoprotein receptors and lipid enzymes in hepatitis C virus entry and early steps of infection.

Authors:  Eve-Isabelle Pécheur
Journal:  Scientifica (Cairo)       Date:  2012-12-23

8.  Identification of aptamer-binding sites in hepatitis C virus envelope glycoprotein e2.

Authors:  Fan Chen; Si-Chong Chen; Jing Zhou; Zhi-De Chen; Fang Chen
Journal:  Iran J Med Sci       Date:  2015-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.